Valuation: Amgen Inc.

Market Cap 236B 215B 198B 180B 338B 21,841B 355B 2,409B 958B 11,929B 885B 866B 37,440B P/E 2026 *
22.5x
P/E 2027 * 21.4x
Enterprise Value 275B 251B 231B 210B 394B 25,486B 414B 2,811B 1,117B 13,920B 1,033B 1,011B 43,687B EV / Sales 2026 *
6.97x
EV / Sales 2027 * 6.53x
Free-Float
99.76%
Yield 2026 *
2.32%
Yield 2027 * 2.45%
1 day-0.15%
1 week-6.45%
Current month-6.52%
1 month-0.75%
3 months+0.44%
6 months+31.39%
Current year+33.10%
1 week 434.51
Extreme 434.51
474.4
1 month 434.51
Extreme 434.51
483.99
Current year 318.21
Extreme 318.21
483.99
1 year 312.38
Extreme 312.385
483.99
3 years 253.3
Extreme 253.3
483.99
5 years 198.64
Extreme 198.64
483.99
10 years 138.83
Extreme 138.83
483.99
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Other

Chief Financial Officer

34,061 0.0063%
13/8/26 Exercice

Executive/Senior Manager

3,756 0.0007%
7/8/26 Free

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-6.45%+29.63%+64.18% 237B
-0.30%-6.68%+29.12%+125.42% 1,204B
+1.25%-5.35%+33.19%+80.42% 643B
+0.94%-2.99%+24.73%+106.93% 501B
-0.60%-1.95%+27.26%+67.32% 378B
+0.69%-9.50%+40.80%+30.23% 327B
+0.41%-4.70%+27.23%+51.59% 285B
+0.81%-4.08%-1.74%+32.71% 270B
-0.06%-0.98%+33.15%+118.99% 207B
-0.25%-5.01%-15.80%-62.38% 172B
Average +0.31%-4.70%+22.76%+61.54% 422B
Weighted average by Cap. +0.37%-5.16%+26.25%+81.49%

Financials

2026 *2027 *
Net sales 39.5B 35.97B 33.15B 30.15B 56.56B 3,657B 59.45B 403B 160B 1,998B 148B 145B 6,269B 41.29B 37.61B 34.65B 31.52B 59.14B 3,823B 62.15B 422B 168B 2,088B 155B 152B 6,554B
Net income 10.52B 9.58B 8.83B 8.03B 15.07B 974B 15.84B 107B 42.72B 532B 39.48B 38.65B 1,670B 10.78B 9.82B 9.05B 8.23B 15.44B 999B 16.23B 110B 43.78B 545B 40.46B 39.61B 1,712B
Net Debt 39.36B 35.85B 33.03B 30.05B 56.37B 3,645B 59.25B 402B 160B 1,991B 148B 145B 6,248B 33.8B 30.79B 28.37B 25.8B 48.41B 3,130B 50.88B 345B 137B 1,710B 127B 124B 5,365B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
20/11/26 USD 435.64 -0.72% 4,942,374
19/11/26 USD 438.82 -1.14% 2,509,979
18/11/26 USD 443.89 -3.07% 2,585,285
17/11/26 USD 457.93 -0.95% 2,034,924
16/11/26 USD 462.32 -0.72% 1,925,827
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
435.64USD
Average target price
437.01USD
Spread / Average Target
+0.32%
  1. Stock Market
  2. Stocks
  3. AMGN Stock